<DOC>
	<DOCNO>NCT00282763</DOCNO>
	<brief_summary>The purpose Study test Safety Effectiveness MK0686 relieve neuropathic ( chronic ) pain experienced patient Postherpetic Neuralgia ( Also Know PHN Post Shingles Pain ) . This early phase trial specific protocol information proprietary publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>A Research Study Evaluate Safety Effectiveness MK0686 Treatment Postherpetic Neuralgia ( Also Known PHN Post Shingles Pain ) ( 0686-005 )</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>Diagnosis postherpetic neuralgia pain last least 6 month Able complete study questionnaire , patient diary , comply daily study medication Patient satisfy current treatment pain control Pregnant nursing female History evidence condition opinion investigator , may interfere study result ( e.g. , diabetic neuropathy fibromyalgia ) pose undue risk undergo course medication require study ( e.g. , unstable heart disease , morbid obesity , kidney liver disease )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>